medigraphic.com
ISSN 0016-3813 (Print)

2006, Number 3

Next >>

Gac Med Mex 2006; 142 (3)

Risk factors associated with neurocysticercosis in a public hospital in México.

Ortiz-Trejo JM, Correa-Chacón AJ, Sotelo-Ham EI, Torres-Valenzuela A, Alvarado-Esquivel C

Language: Spanish
References: 36
Page: 175-179
PDF size: 441.33 Kb.


ABSTRACT

Objective: A case-control study was carried out to determine risk factors associated with neurocysticercosis in a public hospital in Mexico.
Methods: The following factors were analyzed: Socioeconomic, sociodemographic, hygiene, eating habits, and family history of neurocysticercosis in 85 cases and 170 controls. Cases were patients with cranial computed tomography images compatible with neurocysticercosis. The densitometric analysis (Hounsfield units) allowed us to distinguish normal tissue from physiological and pathological calcifications, and other types of lesions. Controls were admitted for neurocysticercosis but findings were not compatible with initial diagnosis. Statistical analysis was done using SPSS® and Epi-info 2002®.
Results: The most common clinical manifestation in patients was epileptic seizures OR=4.2 (IC 95% 2.40-9.67). With regards to risk factors, consumption of street food OR=2.33 (IC 95% 1.25-4.38), and family history of neurocysticercosis OR= 2.37 (IC 95% 1.11-5.04) were found to be associated with neurocysticercosis. In the north central region of Mexico where this study was performed, the disease was more frequent among urban populations.


REFERENCES

  1. Atías MA. Helmintos. En: Parasitología Médica. Publicaciones Técnicas Mediterráneo Ltda. 2a. Edición, Barcelona, 2001, p. 33-36.

  2. Tay ZJ, Velasco CO, Gutiérrez QM. Cisticercosis e hidatidosis. En: Parasitología Médica. Méndez Editores. 7a. Edición, México, 2002, p. 229-241.

  3. Azad R, Grupta RK, Kumar S, Pandey CM, Prasad KN, Husain N, et al. Is neurocysticercosis a risk factor in coexistent intracraneal disease? An MRI, based study. J Neurol Neurosurg Psychiatry 2003;74:359-361.

  4. Townes JM, Hoffmann CH J, Kohn MA. Neurocysticercosis in Oregon, 1995-2000 Emerg Infect Dis 2004;10:508-510.

  5. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002;8:608-613.

  6. Sorvillo FJ, Portigal L, DeGiorgio C, Smith L, Waterman SH, Berlin GW, et al. Cysticercosis-related deaths, California. Emerg Infect Dis 2004;10:465-469.

  7. Gavagan T, Brodyaga L. Medical care for immigrants and refugees. Am Fam Physician. 1998;57:1061-1068. review.

  8. Litt AW, Mohuchy T. Case 10: Neurocysticercosis. Radiology 1999;211:472-476.

  9. Grinspon R, Grippo J. Debemos pensar en neurocisticercosis en nuestro medio. Arch Argent Pediatr 2000;98:329-333

  10. Sarti E. La teniosis y cisticercosis por Taenia solium. Salud Publica Mex 1997;39:225-230.

  11. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, Mukaratirwa S, et al. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 2003;87:13-23.

  12. Bern C, Garcia HH, Evans C, Gonzalez AE, Verasategui M, Tsang VC, et al. Magnitud of the Disease Burden from Neurocysticercosis in a Developing Country. Clin Infect Dis 1999;29:1203-1209.

  13. Gilman RH, Del Brutto OH, García HH, Martínez M. Prevalence of taeniosis among patients with neurocysticercosis is related to severety of infection. The Cysticercosis Working Group in Peru. Neurology 2000;55:1062-1064.

  14. López-Cepeda L, Proaño J, Ambrosio J, Ávila-Ramírez G, Flisser A. Estudio de individuos con taeniosis y su asociación con enfermos con neurocisticercosis. Rev Fac Med UNAM 2001;44:164-167.

  15. Francis A, Burgener, Martii Kormano. Diagnóstico por TC. En: Ed. en español de Differential diagnosis in Computed Tomography (Eds.) Marban Libro S.L. 1a. Edición, New York, 1998, p. 3-12.

  16. Heron E, Hernigou A, Chatellier G, Fornes P, Emmerich J, Fiessinger JN. Intracerebral calcification in systemic sclerosis. Stroke 1999;30:2183-2185.

  17. Agarwal A, Raghav S, Husain M, Kumar R, Gupta RK. Epilepsy with focal cerebral calcification: Role of magnetization transfer MR imaging. Neurol India 2004;52:197-179.

  18. Silva JE, Diefenthaler AP, Palma JK. Frequency of suspected cases of neurocysticercosis detected by computed skull tomography in Santa Maria, RS, Brazil. Rev Inst Med Trop Sao Paulo 2000;42:57-58.

  19. Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 2003;22:139-145.

  20. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-143.

  21. Davila D, Núñez J, Sandoval L, Vega E, Larrea P. Valoración diagnóstica de la tomografía axial computarizada versus Western Blot en Neurocisticercosis. Revista Peruana de Neurología 2002;8:5-10.

  22. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.

  23. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002;59:1730-1734.

  24. Pozo-García MP, Campos-Olazabal P, Burneo J. Neurocysticercosis in a paediatric population in Lima: an epidemiological and clinical analysis. Rev Neurol 2003;36:205-208.

  25. Silva-Vergara ML, Prata A, Netto HV, Vieira C de O, Castro JH, Micheletti LG, et al Risk factors associated with taeniasis-cysticercosis in Lagamar, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 1998;31:65-71.

  26. Sarti E, Schantz PM, Plancarte A, Wilson M, Gutierrez IO, Lopez AS, et al. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg 1992;46: 677-685.

  27. Arambulo P, Almeida CR, Cuellar J, Belotto AJ. Street food vending in Latin America. Bull Pan Am Health Organ 1994;28:344-354.

  28. Parrilla-Carrillo MC, Vázquez-Castellanos JL, Saldate-Castañeda EO, Nava-Fernández LM. Brotes de toxiinfecciones alimentarias de origen microbiano y parasitario. Salud Publica Mex 1993;35:456-463.

  29. Cifuentes E, Blumenthal U, Ruiz-Palacios G, Benett S, Peasy A. Escenario epidemiológico del uso agrícola del agua residual: El Valle del Mezquital, México. Salud Publica Mex 1994; 36:3-9.

  30. Muenning P, Pallin D, Sell RL, Chan MS. The Cost Effectiveness of Strategias for the treatment of Intestinal Parasites in immigrants. N Engl J Med. 1999; 340:773-779.

  31. Larralde C, Padilla A, Hernández M, Govezensky T, Sciutto E, Gutierrez G, et al. Seroepidemiología de la cisticercosis en México Salud Publica Mex 1992;34:197-210.

  32. Goodman K A, Ballagh SA, Carpio A. Case-Control study of seropositive for cysticercosis in Cuenca, Ecuador. Am J Trop Med Hyg 1999;60:70-44.

  33. Ferrer E, Cortez MM, Perez H, De la Rosa M, de Notaba, D‘Avila I, et al. Serological evidence for recent exposure to Taenia solium in Venezuelan Amerindians. Am J Trop Med Hyg 2002;66:170-174.

  34. Garcia HH, Gilman RH, Gonzalez AE, Verastegui M, Rodríguez S, Gaviria C et. al. Hyperendemic human and porcine Taenia solium infection in Perú. Am J Trop Med Hyg 2003;68:268-275.

  35. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G. La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med 1988; 19:351-360.

  36. Del Bruto OH, Dolezal M, Castillo PR, García HH. Neurocisticercosis and oncogénesis. Arch Med Res 2000;31:151-155.




2020     |     www.medigraphic.com